Skip to main content

Advertisement

SpringerLink
Log in

Calculating clinically relevant drug doses to use in animal studies

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, Keck B, Phipps RJ, Burr DB (2008) Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int 19:1331–1341 doi:10.1007/s00198-008-0602-6

    Article  PubMed  CAS  Google Scholar 

  2. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90(5):2816–2822

    Article  PubMed  CAS  Google Scholar 

  3. Seeman E (2006) Strontium ranelate: vertebral and non-vertebral fracture risk reduction. Curr Opin Rheumatol 18(Suppl 1):S17–S20

    Article  PubMed  Google Scholar 

  4. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459–468

    Article  PubMed  CAS  Google Scholar 

  5. Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ (2006) Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21(4):536–542

    Article  PubMed  CAS  Google Scholar 

  6. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104(10):1363–1374

    Article  PubMed  CAS  Google Scholar 

  7. Borchrd R, Barbes C, Eltherington L (1992) Drug dosage in laboratory animals. CRC, Boca Raton, p 514

    Google Scholar 

  8. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8(5):607–615

    Article  PubMed  CAS  Google Scholar 

  9. Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, Lorenc R, Pors-Nielsen S, De Vernejoul MC, Roces A, Reginster JY (2002) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis—a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87(5):2060–2066

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy and Cell Biology, School of Medicine, Indiana University, Indianapolis, IN, USA

    R. K. Fuchs, M. R. Allen, K. W. Condon, S. Reinwald & D. B. Burr

  2. Department of Physical Therapy, School of Health and Rehabilitation Sciences, Indiana University, Indianapolis, IN, USA

    R. K. Fuchs

  3. National Synchrotron Light Source, Brookhaven National Laboratory, Upton, NY, USA

    L. M. Miller

  4. Procter and Gamble Pharmaceuticals, Mason, OH, USA

    D. McClenathan, B. Keck & R. J. Phipps

  5. Department of Orthopaedic Surgery, School of Medicine, Indiana University, Indianapolis, IN, USA

    D. B. Burr

Authors
  1. R. K. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. R. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. W. Condon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Reinwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. M. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. McClenathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Keck
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. J. Phipps
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. B. Burr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. K. Fuchs.

Additional information

This is a reply to the comment that can be found at doi:10.1007/s00198-008-0740-x.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuchs, R.K., Allen, M.R., Condon, K.W. et al. Calculating clinically relevant drug doses to use in animal studies . Osteoporos Int 19, 1815–1817 (2008). https://doi.org/10.1007/s00198-008-0741-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0741-9

Keywords

Search

Navigation